文献速递显微修复重建创面修复

逆行腓肠神经营养血管皮瓣在儿童患者中的应用:一项系统评价

Application of Reverse Sural Flaps in Pediatric Patients: A Systematic Review.
PubMed 文献 · Ann Plast Surg · 2024-12-30

该系统评价与Meta分析检索PubMed、Scopus、CINAHL和ProQuest数据库,纳入16项病例系列或病历研究、共207例儿童(<18岁)逆行腓肠神经营养血管皮瓣(RSF)患者。皮瓣总存活率为91.0%,静脉淤血发生率约13.0%,坏死率15.0%(其中93.1%为部分坏死并经补充植皮处理)。作者认为RSF可考虑作为儿童下肢软组织重建的一线治疗。

要点

  • 儿童RSF皮瓣总存活率为91.0%,静脉淤血发生率约13.0%,坏死率15.0%。
  • 坏死病例中93.1%为部分坏死,经补充皮肤移植成功处理。
  • 软组织缺损主要病因为创伤(91.0%),重建部位多为下肢远端三分之一。

核心结论

  • RSF在儿童下肢远端三分之一缺损中的疗效与游离皮瓣相当,成功率与成人RSF患者相似,作者认为可考虑作为儿童下肢软组织重建的一线治疗。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Scopus、CINAHL和ProQuest数据库,纳入报告儿童RSF患者的病例系列和病历研究。
  • 初筛244篇文章后纳入16项研究进行进一步评价和统计分析,共207例患者,平均年龄9.51±2.27岁,平均随访20.07个月。

主要发现

  • 207例儿童RSF患者的总存活率为91.0%。
  • 约13.0%的患者发生静脉淤血。
  • 皮瓣坏死率为15.0%,其中93.1%为部分坏死并经补充皮肤移植成功处理。
  • 软组织缺损主要病因为创伤(91.0%),多数研究以远端三分之一为主要重建部位,筋膜皮瓣为最常用皮瓣类型。

临床怎么用

  • 作者认为RSF可考虑作为儿童下肢软组织重建的一线治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The reverse sural flap (RSF) is a random-type, pedicled flap based on sural artery perforators indicated for traumatic lower-extremity wounds. The RSF has demonstrated comparable results to free flap placement in the adult population for reconstruction of distal third defects, but few reports describe its application and outcomes in the pediatric population. METHODS: We investigated RSF application in pediatric patients (<18 years of age) through systematic review and meta-analysis. PubMed, Scopus, CINAHL, and ProQuest databases were utilized. Inclusion criteria included case series and chart studies reporting on pediatric RSF patients. Primary outcomes included overall flap survival rate, venous congestion, and necrosis. Screening of 244 initial articles yielded 16 studies for further review and statistical analysis. RESULTS: There were 207 patients treated with a mean age of 9.51 ± 2.27 years and follow-up of 20.07 months. The majority of studies focus on the distal third as the primary site for RSF reconstruction, with fasciocutaneous being the most commonly used flap type. Trauma was the predominant etiology of soft-tissue defect (91.0%). Analysis of outcomes shows a 91.0% survival rate for reverse sural flaps. Approximately 13.0% of patients experienced venous congestion. Flap necrosis rate was 15.0%, although most cases were subtotal (93.1%) and successfully managed through additional skin grafting. CONCLUSIONS: With comparable efficacy to free flaps for distal third defects in the pediatric population as well as similar success rates to adult RSF patients, the RSF should be considered a first-line therapy for lower-extremity soft-tissue reconstruction in pediatric patients.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Wang A, Durand JPF, Dadzie AI, et al. Application of Reverse Sural Flaps in Pediatric Patients: A Systematic Review. Ann Plast Surg. 2024. PMID: 39787373. doi:10.1097/SAP.0000000000004115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。